Retin-A Related Published Studies
Well-designed clinical trials related to Retin-A (Tretinoin Topical)
Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial. [2009.10]
Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study. [2009.09]
Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial. [2009.08]
Comparative efficacy and safety results of two topical combination acne regimens. [2009.07]
Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. [2009.06]
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel. [2009.04]
Association between statin use and risk for keratinocyte carcinoma in the veterans affairs topical tretinoin chemoprevention trial. [2009.01.06]
Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B. [2009.01]
Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole. [2009]
Modulation of plasma all-trans retinoic acid concentrations by the consumption of carotenoid-rich vegetables. [2008.11]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.09]
Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines. [2008.09]
A novel gel formulation of clindamycin phosphate-tretinoin is not associated with acne flaring. [2008.08]
Comparative evaluation of beneficiary effects of priming agents (2% hydroquinone and 0.025% retinoic acid) in the treatment of melasma with glycolic acid peels. [2008.08]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.06.28]
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. [2008.04]
All-trans retinoic acid for treatment of chronic hepatitis C. [2008.03]
Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. [2008.01]
Proliferative changes in the bronchial epithelium of former smokers treated with retinoids. [2007.11.07]
Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage. [2007.11]
Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne. [2007.07]
Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial. [2007.06]
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment. [2007.03.15]
Tretinoin microsphere gel 0.1% for photodamaged facial skin: a placebo-controlled trial. [2006.12]
Feasibility of retinoids for the treatment of emphysema study. [2006.11]
Beneficial effect of a moisturizing cream as adjunctive treatment to oral isotretinoin or topical tretinoin in the management of acne. [2006.11]
Facilitating facial retinization through barrier improvement. [2006.10]
Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies. [2006.09]
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. [2006.09]
Safety and efficacy of Tretin-X compared with Retin-A in patients with mild-to-severe acne vulgaris. [2006.05]
Is interferon-alpha and retinoic acid combination along with radiation superior to chemo-radiation in the treatment of advanced carcinoma of cervix? [2006.04]
Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure. [2006.04]
Two randomized, double-blind, controlled trials of 2219 subjects to compare the combination clindamycin/tretinoin hydrogel with each agent alone and vehicle for the treatment of acne vulgaris. [2006.01]
Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. [2006.01]
'Keratolytic' properties of benzoyl peroxide and retinoic acid resemble salicylic acid in man. [2006]
The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes. [2005.11]
Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study. [2005.09]
Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream. [2005.07]
Exposure to retinoic acids in non-pregnant women following high vitamin A intake with a liver meal. [2005.05]
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%. [2005.04]
9-cis-retinoic acid treatment increases serum concentrations of alpha-tocopherol in former smokers. [2005.03.15]
Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. [2005.01]
Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. [2005]
Well-designed clinical trials possibly related to Retin-A (Tretinoin Topical)
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129. [2009.12]
Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial. [2008.09.03]
Loss of elastic fibers causes skin wrinkles in sun-damaged human skin. [2008.05]
Reliability of the histopathologic diagnosis of keratinocyte carcinomas. [2007.08]
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL97 study. [2007.07.01]
A hydroquinone formulation with increased stability and decreased potential for irritation. [2007.06]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. [2006.12.20]
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. [2006.08]
Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial. [2006.06.15]
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. [2005.07.15]
Other research related to Retin-A (Tretinoin Topical)
Effect of slow-releasing all-trans-retinoic acid in bioabsorbable polymer on delayed adjustable strabismus surgery in a rabbit model. [2009.10]
Beyond tretinoin: cosmeceuticals for aging skin. [2009.07]
Noninvasive ventilation in a pregnant patient with respiratory failure from all-trans-retinoic-acid (ATRA) syndrome. [2009.07]
Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells. [2009.06]
A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years. [2009.05]
Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins. [2009.01.01]
Topical tretinoin therapy and all-cause mortality. [2009.01]
Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters. [2009.01]
The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. [2009]
9-Cis retinoic acid reduces 1alpha,25-dihydroxycholecalciferol-induced renal calcification by altering vitamin K-dependent gamma-carboxylation of matrix gamma-carboxyglutamic acid protein in A/J male mice. [2008.12]
Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. [2008.11.05]
Cosmeceuticals: focus on topical retinoids in photoaging. [2008.11]
Safety of a novel gel formulation of clindamycin phosphate 1.2%-tretinoin 0.025%: results from a 52-week open-label study. [2008.11]
Talarozole, a selective inhibitor of P450-mediated all-trans retinoic acid for the treatment of psoriasis and acne. [2008.11]
Clindamycin phosphate/tretinoin gel formulation in the treatment of acne vulgaris. [2008.11]
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group. [2008.10.15]
Fournier's gangrene and scrotal ulcerations during all-trans-retinoic acid therapy for acute promyelocytic leukemia. [2008.08]
Cumulative irritation potential of topical retinoid formulations. [2008.08]
Tretinoin microsphere gel in younger acne patients. [2008.08]
Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis. [2008.08]
Retinoic acid syndrome: a review. [2008.08]
Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma. [2008.08]
Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells. [2008.07.23]
Retinoic acid receptors, hematopoiesis and leukemogenesis. [2008.07]
All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia. [2008.07]
All-trans retinoic acid induces nerve regeneration and increases serum and nerve contents of neural growth factor in experimental diabetic neuropathy. [2008.07]
Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma. [2008.06.03]
[Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemia] [2008.06]
Interleukin-1beta mediates LPS-induced inhibition of apoptosis in retinoic acid-differentiated HL-60 cells. [2008.05.02]
Pediatric acute promyelocytic leukemia: all-transretinoic acid therapy in a Brazilian pediatric hospital. [2008.05]
Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. [2008.05]
Comparative Evaluation of Beneficiary Effects of Priming Agents (2% Hydroquinone and 0.025% Retinoic Acid) in the Treatment of Melasma with Glycolic Acid Peels. [2008.04.22]
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. [2008.04.01]
Retinoic acid-induced inner ear teratogenesis caused by defective Fgf3/Fgf10-dependent Dlx5 signaling. [2008.04]
Retinoic acid-induced testosterone production and retinoylation reaction are concomitant and exhibit a positive correlation in Leydig (TM-3) cells. [2008.04]
Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. [2008.03.01]
Alitretinoin: a comprehensive review. [2008.03]
Prenatal treatment with retinoic acid promotes pulmonary alveologenesis in the nitrofen model of congenital diaphragmatic hernia. [2008.03]
Retinoic acid prevents germ cell mitotic arrest in mouse fetal testes. [2008.03]
Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice. [2008.03]
Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance. [2008.03]
Retinoids, 585-nm Laser, and Carbon Dioxide Laser: A Numeric Comparison of Neocollagen Formation in Photoaged Hairless Mouse Skin. [2008.02.27]
Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma. [2008.02]
Mononuclear cell extravasation in an inflammatory response is abrogated by all-trans-retinoic acid through inhibiting the acquisition of an appropriate migratory phenotype. [2008.02]
Prenatal treatment with retinoic acid accelerates type 1 alveolar cell proliferation of the hypoplastic lung in the nitrofen model of congenital diaphragmatic hernia. [2008.02]
Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature. [2008.02]
|
